Some information about Flector and other equally effective, less-expensive options available.
In the research analyzed by the OSU College of Pharmacy, Flector demonstrated efficacy over placebo for strains or contusions ranging from mild to moderate when used less than 14 days in only two of four studies.
- The difference in pain relief over placebo was not considered clinically meaningful by one FDA clinical reviewer.
- Flector is systemically absorbed and thus carries the same black-box warnings for cardiovascular and gastrointestinal risk. There is no evidence that Flector offers a safety advantage.
- The patch delivery system brings with it a five percent risk of site reactions and variable absorption associated with heat or flushing.
- Ibuprofen (600-800mg three times daily) or naproxen (250-500mg two times daily) or diclofenac (50 mg three times daily) have strong evidence of efficacy over placebo at a much lower cost. Numerous other generic NSAIDs also provide cost-effective alternatives for patients that do not tolerate ibuprofen, naproxen, or diclofenac.
We recognize that that every injured worker's care is individualized. We appreciate your review of this evidence and consideration of a less costly, medically appropriate alternative.